IRADIMED CORPORATION to Present at Cantor Fitzgerald Global Healthcare Conference
September 18 2017 - 3:00PM
IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger
Susi, President and Chief Executive Officer and Chris Scott, Chief
Financial Officer, will present at the Cantor Fitzgerald Global
Healthcare Conference in New York, NY. Mr. Susi and Mr. Scott
are scheduled to present on Tuesday, September 26th at 3:25 pm
Eastern Time.
Investors may listen to a live webcast and view a copy of the
slide presentation online via the internet
at http://www.iradimed.com/en-us/investors/index.php and
selecting Events & Presentations. The recorded webcast
will be accessible online for at least 30 days.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in the development of MRI
compatible medical devices. We are the only known provider of
non-magnetic intravenous (IV) infusion pump systems that are
specifically designed to be safe for use during magnetic resonance
imaging (MRI) procedures. We were the first to develop an infusion
delivery system that largely eliminates many of the dangers and
problems present during MRI procedures. Standard infusion pumps
contain magnetic and electronic components which can create radio
frequency (RF) interference and are dangerous to operate in the
presence of the powerful magnet that drives an MRI system. Our
patented MRidium® MRI compatible IV infusion pump system has been
designed with a non-magnetic ultrasonic motor, uniquely-designed
non-ferrous parts and other special features in order to safely and
predictably deliver anesthesia and other IV fluids during various
MRI procedures. Our pump solution provides a seamless approach that
enables accurate, safe and dependable fluid delivery before, during
and after an MRI scan, which is important to critically-ill
patients who cannot be removed from their vital medications, and
children and infants who must generally be sedated in order to
remain immobile during an MRI scan.
Our 3880 MRI compatible patient vital signs monitoring system
has been designed with non-magnetic components and other special
features in order to safely and accurately monitor a patient’s
vital signs during various MRI procedures. The IRADIMED 3880
system operates dependably in magnetic fields up to 30,000 gauss,
which means it can operate virtually anywhere in the MRI scanner
room, including in very close proximity to the MRI scanner bore.
The IRADIMED 3880 has a compact, lightweight design allowing
it to travel with the patient from their critical care unit, to the
MRI and back, resulting in increased patient safety through
uninterrupted vital signs monitoring and decreasing the amount of
time critically ill patients are away from critical care units. The
features of the IRADIMED 3880 include: wireless ECG with
dynamic gradient filtering; wireless SpO2 using Masimo® algorithms;
non-magnetic respiratory CO2; non-invasive blood pressure; patient
temperature, and; optional advanced multi-gas anesthetic agent unit
featuring continuous Minimum Alveolar Concentration measurements.
The IRADIMED 3880 MRI compatible patient vital signs
monitoring system has an easy-to-use design and allows for the
effective communication of patient vital signs information to
clinicians. Our 3880 MRI compatible patient vital signs monitoring
system is currently available to international customers. Once we
receive FDA 510(k) clearance, the 3880 will be available to U.S.
customers. We currently anticipate commencing marketing the 3880 to
U.S. customers in the fourth quarter of 2017.
For more information please visit www.iradimed.com.
Media Contact:Chris ScottChief Financial OfficerIRADIMED
CORPORATION(407) 677-8022InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Jul 2023 to Jul 2024